Classifications

• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
  • A61B10/00—Other methods or instruments for diagnosis, e.g. instruments for taking a cell sample, for biopsy, for vaccination diagnosis; Sex determination; Ovulation-period determination; Throat striking implements
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
  • A61B10/00—Other methods or instruments for diagnosis, e.g. instruments for taking a cell sample, for biopsy, for vaccination diagnosis; Sex determination; Ovulation-period determination; Throat striking implements
  • A61B10/02—Instruments for taking cell samples or for biopsy

Definitions

• the present invention rsiaras to a device and a method for the determination of the healing ability of an incisional wound or a connective tissue in man.
• the tissue healing process begins within a matter of seconds from receiving a lesion or starting an operation and continues via blood coagulation and a highly diversified biological reaction chain towards connective tissue cicatrization. What in the beginning is a cell-abundant, slack and mechanically unstable tissue turns into a firmer and firmer tissue as days and weeks pass. Little by. little the metabolism of this granulation tissue becomes slower.
• the shape, final size and microscopic texture of a cicatrix tissue are determined according to the patient's age, sex, general metabolism and local tissue strength requirement.
• An object of the present invention is to improve this device and method for providing a reliably operating, tissue-healing testing device as well as a method which is reliably reproducible and whereby the accuracy of analysis results is improved and their utilization is facilitated.
• a device of the present invention for detecting wound healing ability comprises a flexible capillary tube inserted in a conventional manner into a wound, the tip of this tube left in the wound being fitted with a sponge for the attachment and growth of cells.
• a characterizing feature of this device of the invention is that at least that end of a capillary tube left inside the wound is provided with at least one inner groove and that the sponge is a wet-expanding viscose cellulose sponge, containing macro- and micropores in communication with each other.
• the inner design of a capillary tube according to the invention provides a firm attachment of the sponge to the end of a tube and at the same time there is secured the free entrance and movement for cell-containing wound exudate in the capillary tube and in the sponge.
• the interior of a capillary tube is divided into four substantially equal-sized grooves. This produces two opposite pairs of grooves having therebetween ridges retaining the piece of sponge.
• the viscose cellulose sponge is preferably rectangular in cross-section and so dimensioned that, when dry, it extends from one groove of a capillary tube to the op posite groove, the side grooves remaining free even in the expanded condition of a viscose sponge, whereby the fluid i s allowed a free flow in these free side grooves.
• the capillary tube is preferably made of silicone rubber.
• the invention relates also to a method for the determination of incisional wound healing ability, wherein a sponge mounted on a capillary tube and intended for the attachment and growth of wound cells is inserted in a wound for sampling.
• This invention is characterized in that, after the sampling, the sponge is rinsed with a certain rinsing liquid, at a certain rinsing speed and with a certain amount of rinsing liquid, followed by treating the cell suspension in a per se known manner for differential counting of the cells and and comparing the obtained results with reference values.
• the comparison is most preferably effected by means of a computer.
• the cytological response primarily reveals the responsive ability and strength of an examined individual over the entire healing process. It has been said that wound healing is an indicator of the vitality of a whole individual as it requires the coordinated combined effect of all blood cells, connective tissue cells as well as dozens of different enzymes, catalysts and intermediator substances.
• a device collecting wound cells must be structurally standardized. This is particularly true regarding a cellulose sponge placed inside a slicone rubber tube. Cells are extremely sensitive to even slight changes in the surface texture and pore size of a sponge. Therefore, even microscopically studied, the sponge texture should be homogeneous and dimensionally precisely quantified.
• a method of the invention facilitates the preparation of information obtained from a cellular analysis and suitable for clinical application within a matter of minutes from the moment the data is supplied from a computer terminal. Thereafter, it is possible to collect continuously increasing material for detecting disease-linked and hereditary effects on the healing of tissues.
• fig. 1 shows a device of the invention wrapped in a protective package
• fig. 2 shows a device of the invention implanted in a wound
• fig. 3 shows the sponge-facing end of a capillary tube as an enlarged longitudinal and crosswise section
• fig. 4 shows the same as fig. 3 but the sponge imbibed with fluid
• figs. 5 and 6 show the distribution curves for macro- and micropores in a prior known sponge and in a sponge of the invention.
• a device of the invention comprises a pliable capillary tube 1, which is preferably made of silicone rubber and one end of which is fitted with a wound cells collecting sponge 2.
• this tube 1 of the invention is packed in a transparent protective case 3, in which the capillary tube is fastened to a base sheet by means of protective films.
• the protective films can be readily torn off from the end of capillary tube 1 and, as shown in fig. 1, a plurality of such capillary packages can be koined side by side and removed one by one.
• a capillary tube 1 removed from the package is placed inside a wound as shown in fig. 2.
• a capillary tube 1 is left in this position for e.g. 48 hours with fluid being collected in capillary tube 1 and absorbed in sponge 2.
• the shape of capillary tube 1 and sponge 2 be such that said sponge 2 remains firmly in position also in an expanded condition.
• wound fluid be able to flow freely in capillary tube 1 and the capillary tube not be blocked by expanded sponge 2.
• the capillary tube is provided with at least one inner groove 4, 6.
• the number of grooves 4, 6 is four, comprising pairs of grooves 4, 6 disposed in opposite relation to each other. Thus, between the grooves there are formed ridges 5 pointing towards the centre of the tube.
• a sponge 2 inserted in the end of tube 1 is rectangular in cross-section and so dimensioned that in a cross- section its opposite ends extend into the corresponding inner grooves 4 of a capillary tube leaving the other pair of inner grooves 6 vacant.
• sponge 2 is placed entirely in capillary tube 1 in a manner that, in an expanded condition, said sponge 2 does not extend out of capillary tube 1 (fig. 4).
• a viscose sponge 2 used must be as homogeneous as possible. It must contain both micro- and macropores which are in communication with each other so that wound cells are able to migrate from one pore to another. The sponge must also be clinically clean and so must the capillary tube.
• the macropores refer to pores whose diameter is in the order of 1,0 mm and the micropores refer to pores whose diameter or linear measure is in the order of 10 nm. Since the purpose of a sponge is to collect cells from a surgical wound and to offer them a natural culture medium, its texture is of prime importance in view of the invention and decisive in terms of the function of a viscose sponge. Important in view of the operation is a relative proportion between micro- and macropores, the correct size and shape of pores as well as the openings in the partitions of pores for facilitating the migration of cells from one pore to another.
• a viscose sponge used When studying a human being, it is for practical reasons necessary to employ a small device and, thus, a viscose sponge used is also small.
• the viscose sponge used In order to achieve a preferred result, the viscose sponge used must be as homogeneous as possible. A requirement for this is that there will be as little fluctuations as possible in the pore size distribution of a sponge. The peaks of micro- and macropore distributions must be as narrow as possible, especially the presence of a very large macropore in sponge 2 would nullify the entire analysis process.
• the macropores have been too large in terms of proper functioning by preventing the attachment of cells to the walls of a pore and the macropore distribution has also been too wide (fig. 5). It is important in terms of proper functioning that micropores are as large as possible, distribution mean within the range of 5 - 15 ⁇ m, and macropores respectively as small as possible, distribution mean within the range of 0,4 - 0,9 mm (fig. 6).
• capillary tube 1 Following the sampling, the outer end of capillary tube 1 is attached to a rinsing device, wherein the sponge is rinsed for recovering the cells collected therein for analysis.
• a rinsing device In view of the functioning and reproducibility of the method it is important to employ a certain rinsing agent, rinsing speed and amount of rinsing liquid. When selecting these parameters, care should also be taken that the cells contained in the sponge do not break during the rinsing operation.
• a cellulose sponge cut to a predetermined shape and size and fixed to one end of a silicone rubber tube is imbibed with 0.9 % saline, after which the sampling tube is inserted in the surgical wound in such a way that the open end of the tube is fastened under sterile conditions to the skin with tape.
• the sampling tube is removed from the wound after a given time by pulling lightly.
• the open end of the sampling tube which was on the skin is attached for the rinsing of the sponge to a pump which delivers a constant volume e.g. 2 ml of isotonic citrate solution over a given period, generally 5 seconds.
• the rinsing liquid, the amount and rate of its supply are selected in such a manner that the cells can be removed from the surface and pores of the sponge without damaging the cells.
• sample batches of equal size 200 ⁇ l are taken from the cellular suspension and the samples are centrifuged in a cytocentrifuge at the speed of 1000 rpm for 7 minutes.
• the cells transferred to slides are air-dried, fixed in absolute ethanol and stained according to the May-Grünwald-Giemsa method in an automatic staining apparatus. From these stained slides is performed a differential count of the cells and the results obtained are compared with the reference material obtained from healthy operated patients.
• the healing of the wound is considered normal when the so-called biological healing has progressed as far as the chronological time used for healing requires on a patient of a certain age. If the biological healing, which in this case is measured by the absolute amount of cells in the wound at each point of observation and by the relative proportion of each cell type, has not progressed to the stage required by the chronological healing time, then the healing of the wound has retarded. When biological healing progresses more rapidly than chronological healing, the healing of the wound is taking place more rapidly than average in the same age group. Using the method, for determining the healing speed of a wound requires the existence of comprehensive reference material and its own adp- program.
• the capillary sampling tube is removed 47.8 hours after its insertion into the wound.
• the chronological time used for healing is thus the same, that is, 47.8 hours.
• the cell content of the capillary sampling tube which due to the special structure of this sampling tube corresponds to the type and relative amount of the cells in the surgical wound, is counted subsequent to MGG staining by means of conventional differential counting.
• the values obtained are fed from the computer terminal to be processed by the CELLCO adp-program and to be compared with the reference material.
• Each of the ten cell ratios indicates a particular healing time, some ratios more accurately than others.
• the predicted value of the cell ratios has been taken into account as weighted averages in the adpprogram.
• the cell sample from a wound obtained by means of the sampling tube relating to the invention can, in addition to the foregoing, be studied by means of a variety of biomedical methods in order to solve the special problems relating to the recovery of the patient.
• the most common implantation time is 48 hours. Shorter or longer periods can be employed, whereby the rinsing speed of a rinsing liquid changes accordingly.
• a sampling time of 24 hours requires a slower rinsing speed while a sampling time of 72 hours requires a faster supply speed.

Landscapes

• Health & Medical Sciences (AREA)
• Life Sciences & Earth Sciences (AREA)
• Veterinary Medicine (AREA)
• Medical Informatics (AREA)
• Engineering & Computer Science (AREA)
• Heart & Thoracic Surgery (AREA)
• Molecular Biology (AREA)
• Surgery (AREA)
• General Health & Medical Sciences (AREA)
• Public Health (AREA)
• Pathology (AREA)
• Animal Behavior & Ethology (AREA)
• Biomedical Technology (AREA)
• Investigating Or Analysing Biological Materials (AREA)
• Materials For Medical Uses (AREA)
• Looms (AREA)
• Electrotherapy Devices (AREA)
• Soil Working Implements (AREA)
• Apparatus For Radiation Diagnosis (AREA)
• Media Introduction/Drainage Providing Device (AREA)
• Magnetic Resonance Imaging Apparatus (AREA)
• Catching Or Destruction (AREA)
• Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
• Auxiliary Devices For Music (AREA)
• Investigation Of Foundation Soil And Reinforcement Of Foundation Soil By Compacting Or Drainage (AREA)
• Electrical Discharge Machining, Electrochemical Machining, And Combined Machining (AREA)
• Communication Control (AREA)

Priority Applications (6)

Applications Claiming Priority (2)

Publications (1)

Family

ID=8524799

Family Applications (1)

Country Status (12)

Cited By (1)

Families Citing this family (59)

Citations (7)

• 1987
  • 1987-07-13 FI FI873075A patent/FI77569C/fi not_active IP Right Cessation
• 1988
  • 1988-07-08 KR KR1019890700277A patent/KR890701060A/ko not_active Application Discontinuation
  • 1988-07-08 AT AT88907027T patent/ATE107847T1/de not_active IP Right Cessation
  • 1988-07-08 JP JP63506210A patent/JP2811639B2/ja not_active Expired - Fee Related
  • 1988-07-08 DE DE3850504T patent/DE3850504T2/de not_active Expired - Fee Related
  • 1988-07-08 US US07/457,726 patent/US5113871A/en not_active Expired - Fee Related
  • 1988-07-08 EP EP88907027A patent/EP0395642B1/de not_active Expired - Lifetime
  • 1988-07-08 HU HU884828A patent/HU203276B/hu not_active IP Right Cessation
  • 1988-07-08 WO PCT/FI1988/000113 patent/WO1989000403A1/en active IP Right Grant
  • 1988-07-11 CA CA000571715A patent/CA1325971C/en not_active Expired - Fee Related
  • 1988-07-12 NZ NZ225366A patent/NZ225366A/en unknown
• 1990
  • 1990-01-09 DK DK005990A patent/DK164984C/da active

Patent Citations (7)

Non-Patent Citations (1)

Also Published As

Similar Documents

Legal Events